SurgicalSiteInfection.

The CDC tracks surgical site infections through the National Healthcare Safety Network. The three recognized categories reflect a progression of seriousness:

• Superficial incisional SSI. Infection in the skin and subcutaneous tissue only. Often treatable with outpatient antibiotics and local wound care, though not always.
• Deep incisional SSI. Infection extending into the fascia and muscle layers. Typically requires readmission, IV antibiotics, and often surgical debridement.
• Organ or space SSI. Infection involving the organ or body cavity operated on — the most dangerous category. Common examples include intra-abdominal abscess after abdominal surgery, mediastinitis after cardiac surgery, and prosthetic joint infection after orthopedic implants.

Organ-space infections generate the most significant damages in litigation — longer hospitalizations, implant removal and replacement surgeries, prolonged IV antibiotic courses, and, in the worst cases, sepsis and death. The classification shapes both the medical response and the legal value of the claim.

Not every infection is avoidable, and even with perfect technique some procedures carry intrinsic infection risk. That said, large surveillance studies — including peer-reviewed literature indexed through PubMed — consistently show that a meaningful share of observed SSIs are attributable to specific protocol breaches. Recurring culprits:

• Antibiotic timing failures. Prophylactic antibiotics given too early, too late, or in the wrong dose. The 60-minute pre-incision window is measurable and documented.
• Hair removal with razors instead of clippers. Razor-caused microabrasions are a recognized infection-risk amplifier and have been contraindicated for decades.
• Glucose control failures. Intraoperative hyperglycemia in diabetic and non-diabetic patients is directly associated with increased SSI rates, particularly in cardiac and colorectal cases.
• Sterile-technique breaks. Contaminated instruments, unmasked personnel in the field, gloving failures — each is a documented mechanism of bacterial introduction.
• Normothermia failures. Intraoperative hypothermia below 36°C triples superficial SSI risk for some procedures. Active warming is standard of care.

SCIP was originally a joint initiative of the Centers for Medicare and Medicaid Services and the CDC, and its metrics continue to anchor infection-prevention expectations even after the formal program sunset. The core measures that show up in SSI malpractice cases:

• Antibiotic received within 1 hour before incision. Extended to 2 hours for vancomycin or fluoroquinolones. The rationale is simple — therapeutic tissue concentrations must be present at the moment of incision.
• Appropriate antibiotic selected. Cefazolin for most procedures; broader coverage for colorectal and contaminated cases. Substituting or omitting has documented infection-rate consequences.
• Antibiotic discontinued within 24 hours. Prolonging prophylaxis does not reduce infection risk and may contribute to antibiotic resistance.
• Appropriate hair removal. Clippers rather than razors, immediately before the procedure, never the night before.
• Glucose control for cardiac surgery. Maintaining post-op glucose under 180 mg/dL is associated with significantly reduced SSI rates.
• Normothermia for colorectal surgery. Core temperature at or above 36°C at the close of the procedure.

Each SCIP measure leaves a documentary footprint. A late antibiotic dose is visible in the anesthesia record. A razor used for hair removal is visible in the nursing pre-op documentation. These breaches do not require expert reconstruction — they are written into the chart.

Root-cause analyses of preventable SSIs identify the same failure modes across specialties and institutions:

• Rushed pre-incision verification. The surgical timeout is abbreviated and antibiotic administration is assumed rather than verified. The dose gets charted as given but was administered after the incision.
• Sterile field breaks. A team member brushes a non-sterile surface, a camera cord is not properly draped, a glove is touched to an unsterile area. The break is not called out and the procedure continues.
• Sterile processing failures. Instruments improperly cleaned between cases, autoclave cycles not logged, biological indicators not checked. Central sterile services breakdowns implicate the hospital institutionally.
• Glucose not checked. Intraoperative glucose measurement omitted in a diabetic patient. Post-op glucose allowed to climb without intervention.
• Delayed recognition of post-op infection. The patient reports symptoms, the practice downplays or delays evaluation, the infection progresses to organ-space or sepsis before treatment begins.
• OR traffic. Excessive personnel in the operating room, door openings during the procedure. Each event has been associated with increased SSI risk.

SSI cases often involve multiple defendants because SSI prevention itself is a multi-person, multi-step enterprise. Common defendants:

• Operating surgeon. Responsible for sterile technique in the operative field, for recognizing and treating emerging infection, and — under some protocols — for verifying antibiotic administration before incision.
• Anesthesiologist or CRNA. Typically administers prophylactic antibiotics and is therefore responsible for the 60-minute pre-incision window.
• Circulating and scrub nurses. Responsible for sterile-field maintenance, instrument counts, and documentation of the SCIP measures.
• Sterile-processing department. Where sterilization failures are involved — contaminated or inadequately processed instruments.
• Hospital. Vicariously liable for employed staff and directly liable for institutional failures in infection-control policy, OR design, staffing, or oversight.

Florida’s apportionment rules allow the jury to allocate fault among multiple parties. Early identification of every potential defendant preserves the plaintiff’s recovery against any single defendant’s coverage limits.

The damages arc in SSI cases is often dominated by the cascade of interventions required to address the infection:

• Past medical expenses. Readmission, ICU time where sepsis developed, prolonged IV antibiotics, debridement surgeries, wound-vac therapy, and in implant cases the removal-and-replacement procedure.
• Future medical expenses. Ongoing wound care, antibiotic courses, physical therapy, and the surveillance imaging often required after deep or organ-space infection.
• Lost earnings. Frequently measured in months rather than weeks when an organ-space infection is involved.
• Lost earning capacity. When the infection caused permanent functional impairment — reduced range of motion, chronic pain, amputation in the worst cases.
• Pain and suffering. The procedural burden itself is substantial. Uncapped in Florida after Kalitan (2017).
• Disfigurement. Scarring from debridement and multiple interventions; visible skin changes.
• Wrongful death. In fatal sepsis cases, Florida Statute § 768.21 governs recoverable damages for survivors.

SSI cases often turn on close reading of the anesthesia record and nursing documentation. The documentary sources that matter most:

• Anesthesia record. The antibiotic administration time, recorded against the incision time, is the primary SCIP-breach evidence. A late dose produces a clean breach.
• Nursing OR record. Documents the circulating nurse’s SCIP compliance — hair removal method, antibiotic verification, sterile-field integrity.
• Operative report. The surgeon’s description of the procedure, sterile technique, and any intraoperative concerns. Contrasts with what the nursing record shows.
• Sterile-processing records. Autoclave logs, biological indicator results, tray-content documentation. Central sterile services records are often requested in SSI cases.
• Culture and pathology reports. Identify the infectious organism, which often suggests the source — nosocomial pathogens implicate environmental contamination differently than skin flora.
• Readmission and debridement records. Document the damages cascade and, often, contain retrospective observations about the original surgery.

Florida Statute § 766.102 requires a corroborating expert affidavit before suit is filed. For SSI cases, the expert panel typically includes the specialty surgeon plus an infectious disease physician.

Florida Statute § 95.11(4)(b) governs medical malpractice limitations. For SSIs, discovery is usually the date of infection diagnosis, which can be days to months after the original surgery — and in the case of prosthetic joint infection, sometimes longer. The standard 2-year/4-year/7-year framework applies, with the minor 8th-birthday extension where relevant.

The 90-day pre-suit investigation and § 766.102 corroborating expert affidavit are mandatory before filing. Early engagement with counsel preserves records and narrows evidentiary risk.